Who founded Ictero Medical?

Ictero Medical was founded by Matthew Nojoomi, David Waters, Kovi Bessoff in 2018.

Who are Ictero Medical's investors?

Ictero Medical's investors include Texas HALO Fund, TMC Venture Fund, MedTex Ventures LLC.

How much funding has Ictero Medical raised?

Ictero Medical has disclosed $7.1M raised across 1 round.

Where is Ictero Medical headquartered?

Ictero Medical is headquartered in Houston, US.

Ictero Medical

Houston, US · Founded 2018 · Delaware corporation · 3 known investors

Ictero develops the CholeSafe System, a minimally invasive gallbladder ablation device for treating gallstone disease. The product targets patients seeking surgical outcomes without associated surgical risks.

Biotech Healthtech Medical Devices

Founders & leadership

Ictero Medical was founded in 2018 by Matthew Nojoomi, David Waters, and Kovi Bessoff.

Matthew NojoomiCEO, Co-Founder

David WatersCOO, Co-Founder

Kovi BessoffClinical Research Lead, Co-Founder

Raymond KirkCMO

Board

Ashok GowdaBoard directorPartner, MedTex Ventures; CEO, Biotex Inc. at MedTex Ventures LLC

John FichthornBoard directorFounder and Managing Partner at MedTex Ventures LLC

Investors · 3

Texas HALO FundHouston

TMC Venture FundHouston

MedTex Ventures LLCreportedNorwalkvia Ashok Gowda · board

Reported raises · per SEC filings

Form D private placements

$7.1M disclosed across 1 round · 2021

▶$7.1MraisedApr 2022 · 22 investors · Other Health Care

Rule 506(b)

Officers, directors & promoters on the filing

Matthew NojoomiExecutive Officer, Director
Dr. Raymond KirkExecutive Officer, Director
Ashok GowdaDirector
John FichthornDirector
David WatersExecutive Officer

Offering amount: $7.1M
Amount sold: $7.1M
First sale: Dec 2021
Incorporated: Corporation, Delaware, 2018
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap

Boston Scientific3 shared keywordsBoston Scientific supports external researcher-initiated studies through its Investigator Sponsored Research program, which funds independent investigations addressing disease understanding and treatment gaps of interest to the medical community.

Companies competing with Ictero Medical for the same Google search keywords, organic and paid, via search-intersection analysis.

Non-dilutive funding · 2 SBIR/STTR awards

Federal grants — no equity taken

Agency	Phase	Year	Amount
National Science Foundation	Phase II	2023	$966.6K
National Science Foundation	Phase I	2020	$223.7K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

Frequently asked questions

What does Ictero Medical do?: Ictero develops the CholeSafe System, a minimally invasive gallbladder ablation device for treating gallstone disease. The product targets patients seeking surgical outcomes without associated surgical risks.
Who founded Ictero Medical?: Ictero Medical was founded by Matthew Nojoomi, David Waters, Kovi Bessoff in 2018.
Who are Ictero Medical's investors?: Ictero Medical's investors include Texas HALO Fund, TMC Venture Fund, MedTex Ventures LLC.
How much funding has Ictero Medical raised?: Ictero Medical has disclosed $7.1M raised across 1 round.
Where is Ictero Medical headquartered?: Ictero Medical is headquartered in Houston, US.